DKSH Malaysia and DKSH Singapore were jointly honored with the Platinum WACKER Distributor Award for their outstanding performance in 2020.
Petaling Jaya, Malaysia, December 15, 2021 – DKSH’s Business Unit Performance Materials, a leading distributor of specialty chemicals and ingredients, has been recognized with a first-place award by WACKER, a world-renowned provider of specialty chemicals, for its outstanding distribution performance in Malaysia and Singapore in 2020.
The WACKER “Distributor of the Year” Awards are presented annually to recognize outstanding results and achievements by its distribution partners. The performance criteria for the awards are based on a combination of sales performance metrics and service support to WACKER’s business teams.
DKSH’s partnership with WACKER includes marketing and distribution services, enabling the leading specialty chemicals company to reach more customers in Malaysia and Singapore as well as to drive its ambitious growth targets for WACKER BIOSOLUTIONS through DKSH’s distribution footprint in the key markets.
Danielle Moore, Managing Director of Wacker Chemicals (South Asia), commented: “Despite the challenges brought on by the pandemic, DKSH Malaysia and Singapore have consistently delivered excellent performance and showed great dedication as a key distributor of specialty chemicals and ingredients in Asia Pacific. Congratulations to the team and thank you for the high-level achievement.”
Victor Liew, Director, Performance Materials, Indonesia, Malaysia & Singapore, DKSH, added: “We are honored to receive this prestigious recognition from WACKER, who we have been partnered with for more than seven years in Malaysia and Singapore. This award is a great acknowledgment and further testament to our commitment to continuously delivering growth for WACKER in Southeast Asia.”
The WACKER portfolio as distributed by DKSH includes FERMOPURE®, a brand name for vegan L-cystine and L-cysteine, CAVAMAX®, a trade name for cyclodextrins, CAVACURMIN®, a highly bioavailable curcumin complex, CAVAQ10®, which is a coenzyme Q10 powder as well as BELSIL® and SILFOAM®, silicone products for home and personal care. WACKER is the only company in the world to manufacture all three naturally occurring cyclodextrins, marketing them under the trade names CAVAMAX® W6 (α-cyclodextrin), W7 (β-cyclodextrin) and W8 (γ-cyclodextrin). Additionally, DKSH also distributes HDK® – a trade name for WACKER’s pyrogenic silica that is intended for use in food and pharma, among many other applications.
For further information, please contact:
DKSH Holdings (Malaysia) Berhad
Christy Chow
Manager, Branding & Communications
Phone +60 16 232 3334
christy.hm.chow@dksh.com
DKSH Performance Materials
Daniel Hollister
Senior Manager, Group Marketing
Phone +44 20 8879 5500
daniel.hollister@dksh.com
About WACKER
WACKER is a globally active chemical group headquartered in Munich, Germany. With a wide range of state-of-the-art specialty products, the company is a leader in numerous fields and industries. Its products are required in countless high-growth end-user sectors, such as photovoltaics, electronics, pharmaceuticals and household/personal-care products. With some 14,300 employees and annual sales of around €4.69 billion (2020), the Group operates a global network of 26 production sites, 23 technical competence centers and 52 sales offices. www.wacker.com
About DKSH
DKSH’s purpose is to enrich people’s lives. For more than 150 years, we have been delivering growth for companies in Asia and beyond across our Business Units Healthcare, Consumer Goods, Performance Materials and Technology. As a leading Market Expansion Services provider, we offer sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. The DKSH Business Unit Performance Materials distributes specialty chemicals and ingredients for food, pharmaceutical, personal care and various industrial applications. With 48 innovation centers and regulatory support worldwide, we create cutting-edge formulations that comply with local regulations. With around 1,260 specialists, the Business Unit generated net sales of CHF 1.1 billion in 2020. www.dksh.com/pm